Invivyd, Inc. (IVVD)
2.52
+0.01
(+0.40%)
USD |
NASDAQ |
Jan 09, 16:00
2.55
+0.03
(+1.19%)
After-Hours: 20:00
Invivyd Research and Development Expense (Annual): 137.25M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Amicus Therapeutics, Inc. | 109.36M |
| Relmada Therapeutics, Inc. | 46.18M |
| Arcellx, Inc. | 157.09M |
| ADMA Biologics, Inc. | 1.813M |
| Cidara Therapeutics, Inc. | 71.88M |